The results of this study clearly indicate the potential of a low cTnI concentration in first morning urine samples to be a new specific biomarker in patients with severe AS, which is the main novelty of this research in the field of cardiovascular event prediction and diagnosis. This evidence concerns the gene TNNI3 and aortic stenosis.